Abraham Weizman
Overview
Explore the profile of Abraham Weizman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
590
Citations
7063
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Kamhi-Nesher S, Taub S, Halimi S, Frenkel M, Azam M, Bormant G, et al.
Ther Adv Psychopharmacol
. 2022 Jun;
12:20451253221094435.
PMID: 35720508
Background: Therapeutic drug monitoring (TDM) is useful to assess clozapine adherence and optimize treatment. However, analysis of venous blood levels by liquid chromatography tandem mass spectrometry (LC-MS/MS) is often logistically...
32.
Kertzman S, Vainder M, Spivak B, Goclaw Y, Markman U, Weizman A, et al.
Psychol Res Behav Manag
. 2022 Jun;
15:1347-1357.
PMID: 35669110
Background: Over-reporting of posttraumatic stress disorder (PTSD) symptoms has been observed in some cases, following a motor vehicle accident (MVA). It has been suggested, however, that these are cases of...
33.
Merzon E, Weiss M, Krone B, Cohen S, Ilani G, Vinker S, et al.
Int J Environ Res Public Health
. 2022 May;
19(10).
PMID: 35627530
This study examines the demographic, clinical and socioeconomic factors associated with diagnosis of long COVID syndrome (LCS). Data of 20,601 COVID-19-positive children aged 5 to 18 years were collected between...
34.
Levy T, Peskin M, Kohn Y, Sheinhorn S, Schoen G, Weizman A, et al.
Clin Child Psychol Psychiatry
. 2022 May;
27(4):978-990.
PMID: 35608436
Background: Attention-deficit/hyperactivity disorder (ADHD) is associated with increased risk for conduct problems (CP), as well as with callous-unemotional traits (CUt) and lower accuracy in face emotional recognition (FER). It is...
35.
Kertzman S, Kagan A, Vainder M, Lapidus R, Weizman A
BMC Psychol
. 2022 May;
10(1):127.
PMID: 35596176
Although the connection between smoking and individual differences has been recently recognized, the relationship between narcissistic personality traits and cigarette smoking has received less attention. The notion that personality traits...
36.
Amitai M, Kaffman S, Kroizer E, Lebow M, Magen I, Benaroya-Milshtein N, et al.
Brain Behav Immun
. 2022 Apr;
104:31-38.
PMID: 35470013
Background: Both the neutrophil/lymphocyte ratio (NLR) and the platelet/lymphocyte ratio (PLR) have been proposed as biomarkers of suicidal risk in adults with depression. We examined whether these ratios may be...
37.
Monga S, Fares B, Yashaev R, Melamed D, Kahana M, Fares F, et al.
J Fungi (Basel)
. 2022 Mar;
8(3).
PMID: 35330323
Macrophages are some of the most important immune cells in the organism and are responsible for creating an inflammatory immune response in order to inhibit the passage of microscopic foreign...
38.
Taler M, Gil-Ad I, Brener I, Hornfeld S, Weizman A
Int J Mol Sci
. 2022 Mar;
23(5).
PMID: 35269853
Some selective serotonin reuptake inhibitors (SSRIs), primarily sertraline, demonstrate anti-proliferative activity in malignant cell-lines and in xenografted mouse models of colorectal tumor. There is, however, a paucity of comparative studies...
39.
Lavan O, Peled O, Avishai-Neumann M, Weizman A, Yahel A, Apter A, et al.
J Child Adolesc Psychopharmacol
. 2022 Mar;
32(3):153-161.
PMID: 35255222
The aim of this study was to characterize the clinical profiles, tolerability, and efficacy of two groups of antidepressants, selective serotonin reuptake inhibitors (SSRIs), and the atypical antidepressant, mirtazapine, in...
40.
De Leon J, Schoretsanitis G, Smith R, Molden E, Solismaa A, Seppala N, et al.
Pharmacopsychiatry
. 2022 Jan;
55(2):e1.
PMID: 35052001
No abstract available.